118th Congress · HOUSE BILLBILL

H.R. 5429Medication Affordability and Patent Integrity Act

To require sponsors of drug applications and holders of approved applications to provide certain submissions and communications to the Food and Drug Administration and the United States Patent and Trademark Office.

Commerce
Introduced Sep 13, 2023
Last action Sep 15, 2023
Pipeline · Bill → Law
Step 1
Introduced
Sep 13, 2023
Step 2
Referred
Sep 15, 2023
E&C · Judiciary
Step 3
Committee
Step 4
House floor
Step 5
Senate
Step 6
Resolve Changes
Step 7
Signed
SummaryNo summary available

No CRS summary available for this bill.

Provisions · 2 sectionsIntroduced in House
Timeline · 4 actions
Sep 15, 2023
Referred to the Subcommittee on Health.
Sep 13, 2023
Introduced in House
Sep 13, 2023
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Sep 13, 2023
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.